Patient Guide: A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 39 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06864169
Status: 🟢 Enrolling Now
Condition: Gastrointestinal Cancer
Phase: PHASE2

Where You Can Participate

This study is available at 39 locations across the country.

Top locations include:
  • • New Haven, Connecticut
  • • Washington, District of Columbia
  • • Miami Beach, Florida
  • • And 36 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005) - Join Clinical Trial NCTNCT06864169

How to Join This Clinical Trial - NCTNCT06864169

Learn how to participate in this PHASE2 trial studying an investigational therapy for Gastrointestinal Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Gastrointestinal Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Gastrointestinal Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06864169 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 39 locations. Find a study site near you:

Clinical Research Site

New Haven, Connecticut 06510 - United States

Status: RECRUITING

Clinical Research Site

Washington, District of Columbia 20016 - United States

Status: RECRUITING

Clinical Research Site

Miami Beach, Florida 33140 - United States

Status: RECRUITING

Clinical Research Site

Billings, Montana 59102 - United States

Status: RECRUITING

Clinical Research Site

Morristown, New Jersey 07960 - United States

Status: RECRUITING

Clinical Research Site

Cleveland, Ohio 44106 - United States

Status: RECRUITING

Clinical Research Site

Charlottesville, Virginia 22903 - United States

Status: RECRUITING

Clinical Research Site

Madison, Wisconsin 53792 - United States

Status: RECRUITING

Clinical Research Site

Mar del plata, Buenos Aires B7600FZO - Argentina

Status: RECRUITING

Clinical Research Site

Ciudad Autonoma de Buenos Aires, Caba C1431FWO - Argentina

Status: RECRUITING

And 29 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Gastrointestinal Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships